secwatch.observer — SEC 8-K summary
======================================

Issuer:     SHOULDER INNOVATIONS, INC. (SI)
CIK:        0001699350
Form:       8-K
Filed at:   2026-05-13T20:08:18+00:00
Accession:  0001699350-26-000033
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shoulder Innovations Q1 revenue up 65% to $16.7M, raises FY2026 guidance to $65-68M
--------------------------------------------------------------------------------

- Net revenue $16.7M (+65% YoY); implant systems sold 2,184 (+51%); gross margin 77.7%.
- Raised FY2026 net revenue guidance to $65-68M from $62-65M, representing 37-44% YoY growth.
- Operating loss $9.0M, net loss $8.4M; adjusted EBITDA loss $7.0M; cash and marketable securities $108.5M.
- Full commercial launch of InSet I-135RFX Humeral Stem after FDA clearance for additional fracture indications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699350/000169935026000033/0001699350-26-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699350/000169935026000033/si-20260513.htm
  HTML page:      https://secwatch.observer/filing/0001699350-26-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer